CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 72 filers reported holding CATALYST BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $89,000 | +74.5% | 21,563 | +82.8% | 0.01% | +100.0% |
| Q2 2021 | $51,000 | -81.6% | 11,794 | -78.6% | 0.00% | -85.0% |
| Q1 2021 | $277,000 | +25.9% | 55,000 | +58.0% | 0.02% | +33.3% |
| Q4 2020 | $220,000 | +24.3% | 34,800 | -15.4% | 0.02% | +25.0% |
| Q3 2020 | $177,000 | +37.2% | 41,111 | +87.7% | 0.01% | +33.3% |
| Q2 2020 | $129,000 | +22.9% | 21,900 | -8.6% | 0.01% | +12.5% |
| Q1 2020 | $105,000 | +31.2% | 23,949 | +104.7% | 0.01% | +60.0% |
| Q4 2019 | $80,000 | -41.6% | 11,700 | -58.1% | 0.01% | -37.5% |
| Q3 2019 | $137,000 | -33.5% | 27,900 | 0.0% | 0.01% | -33.3% |
| Q2 2019 | $206,000 | – | 27,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |